Treating COPD in Older and Oldest Old Patients

被引:25
|
作者
Corsonello, Andrea [1 ]
Scarlata, Simone [2 ]
Pedone, Claudio [2 ]
Bustacchini, Silvia [3 ]
Fusco, Sergio [1 ]
Zito, Anna [2 ]
Incalzi, Raffaele Antonelli [2 ]
机构
[1] INRCA, Unit Geriatr Pharmacoepidemiol, Cosenza, Italy
[2] Univ Campus Biomedico, Chair Geriatr Med, Rome, Italy
[3] INRCA, Sci Direct, Cosenza, Italy
关键词
Older; chronic obstructive pulmonary disease (COPD); long-acting antichilinergics (LAMA); long-acting beta agonists (LABA); comorbidity; adherence; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; METERED-DOSE INHALER; PRACTICAL MANAGEMENT PROBLEMS; CHRONIC RESPIRATORY-FAILURE; CONTINUOUS OXYGEN-THERAPY; CILIARY BEAT FREQUENCY; AIR-FLOW OBSTRUCTION; DRY POWDER INHALERS; ACUTE EXACERBATIONS;
D O I
10.2174/1381612821666150130121229
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The treatment of older and oldest old patients with COPD poses several problems and should be tailored to specific outcomes, such as physical functioning. Indeed, impaired homeostatic mechanisms, deteriorated physiological systems, and limited functional reserve mainly contribute to this complex scenario. Therefore, we reviewed the main difficulties in managing therapy for these patients and possible remedies. Inhaled long acting beta-agonists (LABA) and anticholinergics (LAMA) are the mainstay of therapy in stable COPD, but it should be considered that pharmacological response and safety profile may vary significantly in older patients with multimorbidity. Their association with inhaled corticosteroids is recommended only for patients with severe or very severe airflow limitation or with frequent exacerbations despite bronchodilator treatment. In hypoxemic patients, long-term oxygen therapy (LTOT) may improve not only general comfort and exercise tolerance, but also cognitive functions and sleep. Non-pharmacological interventions, including education, physical exercise, nutritional support, pulmonary rehabilitation and telemonitoring can importantly contribute to improve outcomes. Older patients with COPD should be systematically evaluated for the presence of risk factors for non-adherence, and the inhaler device should be chosen very carefully. Comorbidities, such as cardiovascular diseases, chronic kidney disease, osteoporosis, obesity, cognitive, visual and auditory impairment, may significantly affect treatment choices and should be scrutinized. Palliative care is of paramount importance in end-stage COPD. Finally, treatment of COPD exacerbations has been also reviewed. Therapeutic decisions should be founded on a careful assessment of cognitive and functional status, comorbidity, polypharmacy, and age-related changes in pharmacokinetics and pharmacodynamics in order to minimize adverse drug events, drug-drug or drug-disease interactions, and non-adherence to treatment.
引用
收藏
页码:1672 / 1689
页数:18
相关论文
共 50 条
  • [1] Treating Cancer in Older and Oldest Old Patients
    Colloca, G.
    Corsonello, A.
    Marzetti, E.
    Balducci, L.
    Landi, F.
    Extermann, M.
    Scambia, G.
    Cesari, M.
    Carreca, I.
    Monfardini, S.
    Bernabei, R.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1699 - 1705
  • [2] Treating Heart Failure in Older and Oldest Old Patients
    Vetrano, Davide Liborio
    Lattanzio, Fabrizia
    Martone, Anna Maria
    Landi, Francesco
    Brandi, Vincenzo
    Topinkova, Eva
    Onder, Graziano
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1659 - 1664
  • [3] Treating Diabetes Mellitus in Older and Oldest Old Patients
    Abbatecola, A. M.
    Paolisso, G.
    Sinclair, A. J.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1665 - 1671
  • [4] Treating Sarcopenia in Older and Oldest Old
    Martone, Anna Maria
    Lattanzio, Fabrizia
    Abbatecola, Angela Marie
    La Carpia, Domenico
    Tosato, Matteo
    Marzetti, Emanuele
    Calvani, Riccardo
    Onder, Graziano
    Landi, Francesco
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1715 - 1722
  • [5] Diagnosing and Treating Depression in Older and Oldest Old
    Morichi, V.
    Dell'Aquila, G.
    Trotta, F.
    Belluigi, A.
    Lattanzio, F.
    Cherubini, A.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1690 - 1698
  • [6] Treating Cancer and No-Cancer Pain in Older and Oldest Old Patients
    Colloca, G.
    Lattanzio, F.
    Balducci, L.
    Onder, G.
    Ronconi, G.
    Landi, F.
    Morlans, G.
    Bernabei, R.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1706 - 1714
  • [7] Treating Major Age-Related Diseases in Older and Oldest Old Patients.
    Corsonello, Andrea
    Cherubini, Antonio
    Lattanzio, Fabrizia
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) : 1656 - 1658
  • [8] Treating osteoporosis in the oldest old
    Abrahamsen, Bo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (06) : 629 - 630
  • [9] Biomarkers of Alzheimer's disease in older and oldest old patients
    Lilamand, Matthieu
    Cognat, Emmanuel
    Goutagny, Stephane
    Hourregue, Claire
    Hugon, Jacques
    Dumurgier, Julien
    Paquet, Claire
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2019, 17 (01): : 65 - 72
  • [10] DRIVING BEHAVIORS AMONG THE OLDER OLD AND OLDEST OLD
    Gaines, J.
    Marx, K.
    Hannum, S. M.
    Ballew, S.
    Burke, K.
    Parrish, J. M.
    GERONTOLOGIST, 2009, 49 : 321 - 321